The Efficacy of Manganese Oxide (Mn2O3) Nanoparticles and Tellurium Oxide (TeO2) Nanorods Against Leishmania Lesions in Female Albino Rats.

Leishmaniasis is a group of diseases caused by infection with Leishmania parasites. The lesions that develop as a result of leishmaniasis can vary depending on the species of the parasite and the type of leishmaniasis. Cutaneous leishmaniasis is the most common form of the disease and it results in skin sores or ulcers. Materials with manganese oxide (Mn2O3) nanoparticles and tellurium oxide (TeO2) nanorods have been shown to have antibacterial, antifungal, and antiparasitic effects. The purpose of this study was to ascertain how Mn2O3 and TeO2 nanoparticles affected Leishmania major-caused wound healing in rats. The albino rats were separated into four groups of five once a lesion appeared on their tails. In the two treatment groups, Mn2O3 and TeO2 nanoparticles were injected every day, once a day, intra-wound in three places, and in the meglumine antimoniate group, the drug was injected intramuscularly for five weeks. The albino rats in the negative control group did not receive any medication. The size of the wounds in the group treated with Mn2O3 nanoparticles did not differ significantly from the control group that did not receive treatment, however the diameter of the wounds in the group treated with TeO2 nanorods did change significantly from the control group that did not receive treatment. It was, however, larger than the group that received meglumine antimoniate treatment. TeO2 nanorods, as opposed to Mn2O3 nanoparticles, had an in vivo anti-Leishmanial potential. [ABSTRACT FROM AUTHOR]